The article offers information on the move of China to boost its disease surveillance, drug stockpiling and vaccine development due to fear of the pandemic influenza H1N1. It mentions that the state is focused on screening those people who are entering the country and on monitoring the respiratory illness of those who are in contact with the illness. It relates that the government has been taking all measures to strategically hamper the spread of the disease.